We are live on ! Find out more
PAHC icon

Phibro Animal Health

172 hedge funds and large institutions have $436M invested in Phibro Animal Health in 2024 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 66 increasing their positions, 36 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 18

83% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 36

17% more funds holding

Funds holding: 147172 (+25)

2.33% more ownership

Funds ownership: 99.74%102.07% (+2.3%)

5% less capital invested

Capital invested by funds: $457M → $436M (-$20.9M)

Holders
172
Holders Change
+25
Holders Change %
+17.01%
% of All Funds
2.27%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
44
Increased
66
Reduced
36
Closed
18
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CAG
76
Csenge Advisory Group
Florida
$434K +$479K +20,687 New
Jane Street
77
Jane Street
New York
$431K -$540K -23,334 -53%
Bank of America
78
Bank of America
North Carolina
$431K -$251K -10,847 -35%
Walleye Capital
79
Walleye Capital
New York
$422K +$465K +20,095 New
PA
80
Pinnacle Associates
New York
$420K -$95.3K -4,120 -17%
SCM
81
Semanteon Capital Management
Massachusetts
$417K +$459K +19,860 New
State of Tennessee, Department of Treasury
82
State of Tennessee, Department of Treasury
Tennessee
$410K +$73K +3,153 +19%
D.E. Shaw & Co
83
D.E. Shaw & Co
New York
$405K -$1.33M -57,612 -75%
California State Teachers Retirement System (CalSTRS)
84
California State Teachers Retirement System (CalSTRS)
California
$399K -$5.39K -233 -1%
Thrivent Financial for Lutherans
85
Thrivent Financial for Lutherans
Minnesota
$399K -$41.1K -1,776 -9%
SCM
86
Sterling Capital Management
North Carolina
$394K +$10.4K +448 +2%
Canada Life
87
Canada Life
Manitoba, Canada
$387K
T. Rowe Price Associates
88
T. Rowe Price Associates
Maryland
$372K +$36.2K +1,565 +10%
HSBC Holdings
89
HSBC Holdings
United Kingdom
$372K +$143K +6,169 +53%
FHB
90
First Hawaiian Bank
Hawaii
$371K
DTL
91
Dynamic Technology Lab
Singapore
$356K +$392K +16,929 New
Deutsche Bank
92
Deutsche Bank
Germany
$354K +$186K +8,032 +91%
GCP
93
GSA Capital Partners
United Kingdom
$346K +$381K +16,464 New
NSEDCP
94
NJ State Employees Deferred Compensation Plan
New Jersey
$336K
Susquehanna International Group
95
Susquehanna International Group
Pennsylvania
$336K +$96.2K +4,157 +35%
BNP Paribas Financial Markets
96
BNP Paribas Financial Markets
France
$327K -$202K -8,748 -36%
Ohio Public Employees Retirement System (OPERS)
97
Ohio Public Employees Retirement System (OPERS)
Ohio
$323K +$356K +15,376 New
Russell Investments Group
98
Russell Investments Group
United Kingdom
$317K +$162K +7,011 +87%
IC
99
IEQ Capital
California
$302K +$332K +14,358 New
SOW
100
State of Wyoming
Wyoming
$297K +$127K +5,483 +63%

PAHC Hedge Fund Activity: Q4 2024 in Review

172 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Phibro Animal Health (PAHC) for Q4 2024, worth a combined $436M — down 4.6% from $457M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new PAHC positions and 18 closed out — a net gain of 26 holders — while 66 added to existing stakes and 36 trimmed.

The largest buyer was BlackRock, adding an estimated $5M. The largest seller was Brandes Investment Partners, cutting an estimated $19M.

  • 172 institutional investors held Phibro Animal Health (PAHC) as of Q4 2024, up from 147 in Q3 2024.
  • Funds reported $436M of Phibro Animal Health stock for Q4 2024, down 4.6% quarter-over-quarter.
  • 44 funds opened new Phibro Animal Health positions in Q4 2024 and 18 closed out, a net change of +26 holders.
  • The largest Phibro Animal Health buyer in Q4 2024 was BlackRock, an estimated $5M added.
  • The largest Phibro Animal Health seller in Q4 2024 was Brandes Investment Partners, an estimated $19M sold.

Based on aggregated 13F filings for Q4 2024.